Novel Small‐molecule Agonists of Human Formyl Peptide Receptors and Pharmacophore Models of their Recognition

Liliya N Kirpotina,Andrei I Khlebnikov,Igor A Schepetkin,Richard D Ye,Marie‐Josèphe Rabiet,Mark A Jutila,Mark T Quinn

DOI: https://doi.org/10.1096/fasebj.24.1_supplement.966.4

2010-04-01

The FASEB Journal

Abstract:N‐formyl peptide receptors (FPR) are G protein‐coupled receptors involved in host defense and sensing cellular dysfunction. Our recent high‐throughput screening efforts have focused on the identification of unique non‐peptide agonists of FPR1/FPR2. In the present studies, we screened a chemolibrary of drug‐like molecules for their ability to induce intracellular calcium mobilization in RBL‐2H3 cells transfected with human FPR1 or FPR2. Screening resulted in the identification of novel and potent agonists that were specific for either FPR1 or FPR2 with EC 50 values in the low micromolar range. Specificity of the compounds was supported by analysis of calcium mobilization in HL‐60 cells transfected with human FPR1 and FPR2. Additionally, all but one agonist activated intracellular calcium flux and chemotaxis in human neutrophils. Molecular modeling of the group of FPR1 and FPR2 agonists using field point methodology allowed us to create pharmacophore models for ligand binding sites and formulate requirements for these specific N‐formyl peptide receptor agonists. These studies further demonstrate that agonists of FPR1/FPR2 include compounds with wide chemical diversity and that analysis of such compounds can enhance our understanding of FPR ligand/receptor interactions. This work was supported in part by NIH grants P20 RR‐020185 and P01 AT0004986‐01, and contract HHSN266200400009C.